Literature DB >> 10606178

N-acetylglucosaminyltransferase V activity in metastatic models of human hepatocellular carcinoma in nude mice.

D M Shao1, Q H Wang, C Chen, Z H Shen, M Yao, X D Zhou, Z Y Tang, J X Gu.   

Abstract

N-linked beta 1-6 branched oligosaccharides may contribute directly to the malignant phenotype including metastatic potential of tumour cells. Increased beta 1-6 branching was associated with an increased level of N-acetylglucosaminyltransferase V (GnT V). In this report, the tissues from two metastatic models of human hepatocellular carcinoma (HCC) in nude mice were obtained. GnT V activity and mRNA level were determined. Results showed that GnT V activity in highly metastatic LCI-D20 models (Liver Cancer Institute, passage time: 20 days) (413.1+/-86.4U) was much higher than that in low metastatic LCI-D35 model (passage time 35 days) (155.3+/-31.9U). Northern blot showed that the mRNA level of GnT V in two models had no change. During the selection of a highly metastatic LCI-D20 model, GnT V activity increased from 301.6+/-57.3U to 413.1+/-86.4U while the highly metastatic LCI-D20 model acquired higher metastatic ability after selection. When highly metastatic LCI-D20 model tissues were implanted subcutaneously (s.c.), the GnT V activity decreased dramatically from 413.1+/-86.4U to 94.9U. This is the first report that GnT V activity increased in HCC during metastasis in vivo.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10606178

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  10 in total

1.  Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97.

Authors:  Y Li; Z Y Tang; S L Ye; Y K Liu; J Chen; Q Xue; J Chen; D M Gao; W H Bao
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

Review 2.  Hepatocellular carcinoma--cause, treatment and metastasis.

Authors:  Z Y Tang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

Review 3.  Metastatic human hepatocellular carcinoma models in nude mice and cell line with metastatic potential.

Authors:  Z Y Tang; F X Sun; J Tian; S L Ye; Y K Liu; K D Liu; Q Xue; J Chen; J L Xia; L X Qin; S L Sun; L Wang; J Zhou; Y Li; Z C Ma; X D Zhou; Z Q Wu; Z Y Lin; B H Yang
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

Review 4.  A decade's studies on metastasis of hepatocellular carcinoma.

Authors:  Zhao-You Tang; Sheng-Long Ye; Yin-Kun Liu; Lun-Xiu Qin; Hui-Chuan Sun; Qin-Hai Ye; Lu Wang; Jian Zhou; Shuang-Jian Qiu; Yan Li; Xue-Ning Ji; Hu Liu; Jing-Ling Xia; Zhi-Quan Wu; Jia Fan; Zeng-Chen Ma; Xin-Da Zhou; Zhi-Ying Lin; Kang-Da Liu
Journal:  J Cancer Res Clin Oncol       Date:  2003-12-18       Impact factor: 4.553

Review 5.  Experimental mouse models for hepatocellular carcinoma research.

Authors:  Femke Heindryckx; Isabelle Colle; Hans Van Vlierberghe
Journal:  Int J Exp Pathol       Date:  2009-08       Impact factor: 1.925

Review 6.  Liver carcinogenesis: rodent models of hepatocarcinoma and cholangiocarcinoma.

Authors:  Samuele De Minicis; Tatiana Kisseleva; Heather Francis; Gianluca Svegliati Baroni; Antonio Benedetti; David Brenner; Domenico Alvaro; Gianfranco Alpini; Marco Marzioni
Journal:  Dig Liver Dis       Date:  2012-11-22       Impact factor: 4.088

Review 7.  The Oncopig Cancer Model: An Innovative Large Animal Translational Oncology Platform.

Authors:  Kyle M Schachtschneider; Regina M Schwind; Jordan Newson; Nickolas Kinachtchouk; Mark Rizko; Nasya Mendoza-Elias; Paul Grippo; Daniel R Principe; Alex Park; Nana H Overgaard; Gregers Jungersen; Kelly D Garcia; Ajay V Maker; Laurie A Rund; Howard Ozer; Ron C Gaba; Lawrence B Schook
Journal:  Front Oncol       Date:  2017-08-23       Impact factor: 6.244

8.  Sorafenib induced alteration of protein glycosylation in hepatocellular carcinoma cells.

Authors:  Tianhua Liu; Riqiang Liu; Shu Zhang; Kun Guo; Qinle Zhang; Wei Li; Yinkun Liu
Journal:  Oncol Lett       Date:  2017-05-16       Impact factor: 2.967

9.  Alteration in N -acetylglucosaminyltransferase activities and glycan structure in tissue and bile glycoproteins from extrahepatic bile duct carcinoma.

Authors:  Xiao-Ling Jin; Hou-Bao Liu; Ying Zhang; Bing-Sheng Wang; Hui-Li Chen
Journal:  Glycoconj J       Date:  2004       Impact factor: 3.009

10.  HCA519/TPX2: a potential T-cell tumor-associated antigen for human hepatocellular carcinoma.

Authors:  Ahmed M Aref; Neil T Hoa; Lisheng Ge; Anshu Agrawal; Maria Dacosta-Iyer; Nils Lambrecht; Yi Ouyang; Andrew N Cornforth; Martin R Jadus
Journal:  Onco Targets Ther       Date:  2014-06-13       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.